Retrospective Analysis of a Population of Patients With With Severe

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Observational retrospective study that included all patients meeting the inclusion criteria from 1st January 2014 to 31st December 2015.

The objective of the study is to describe and compare two populations of patients with severe traumatic head injury arriving under sedation in the Department in whom the sedation was not continued.

NCT number	NCT03293420
Study type	Observational
Source	Centre Hospitalier Universitaire Dijon
Contact
Status	Completed
Phase	N/A
Start date	May 2016
Completion date	December 2016

Status	Clinical Trial	Phase
Terminated	`NCT01810276` - Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury	N/A
Not yet recruiting	`NCT06273267` - Initiating Pediatric Palliative Care in ACT Group 4
Enrolling by invitation	`NCT05299736` - Human Impact Exposure Onboard High-Speed Boats

Retrospective Analysis of a Population of Patients With With Severe Traumatic Head Injury and Woken Early — PRECOCE TC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms